Alternative Commercialisation Models Offer Lifeline to Future of Gene Therapies

Dec 24

Written By Deanna Portero

Deanna Portero

Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Non-Profit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US